Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Kelly

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1989
The pharmacokinetics of paroxetine in renal impairmentG D Doyle, M Laher, J G Kelly, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 1988
A study of the potential pharmacokinetic interaction of lisinopril and digoxin in normal volunteersM J Vandenburg, F Morris, C Marks, et al.
British Journal of Clinical Pharmacology|July 1, 1984
Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithiumS J Cooper, J G Kelly, G D Johnston, et al.
Postgraduate Medical Journal|January 1, 1977
The development of mexiletine in the management of ventricular dysrhythmiasN P Campbell, N C Chaturvedi, R G Shanks, et al.
British Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics of enalapril in normal subjects and patients with renal impairmentJ G Kelly, G Doyle, J Donohue, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Altered vascular function in young women with polycystic ovary syndromeChristopher J G Kelly, Angela Speirs, Gwyn W Gould, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacokinetics of oral acetyl-L-carnitine in renal impairmentJ G Kelly, S Hunt, G D Doyle, et al.
Lancet (London, England)|August 25, 1973
Mexiletine (Kö 1173) in the management of ventricular dysrhythmiasN P Campbell, J G Kelly, R G Shanks, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Pharmacokinetics of amlodipine in renal impairmentM S Laher, J G Kelly, G D Doyle, et al.
Clinical Pharmacology and Therapeutics|November 1, 1976
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blockerH C Brown, S G Carruthers, G D Johnston, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1989
The pharmacokinetics of paroxetine in renal impairmentG D Doyle, M Laher, J G Kelly, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 1988
A study of the potential pharmacokinetic interaction of lisinopril and digoxin in normal volunteersM J Vandenburg, F Morris, C Marks, et al.
British Journal of Clinical Pharmacology|July 1, 1984
Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithiumS J Cooper, J G Kelly, G D Johnston, et al.
Postgraduate Medical Journal|January 1, 1977
The development of mexiletine in the management of ventricular dysrhythmiasN P Campbell, N C Chaturvedi, R G Shanks, et al.
British Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics of enalapril in normal subjects and patients with renal impairmentJ G Kelly, G Doyle, J Donohue, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Altered vascular function in young women with polycystic ovary syndromeChristopher J G Kelly, Angela Speirs, Gwyn W Gould, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacokinetics of oral acetyl-L-carnitine in renal impairmentJ G Kelly, S Hunt, G D Doyle, et al.
Lancet (London, England)|August 25, 1973
Mexiletine (Kö 1173) in the management of ventricular dysrhythmiasN P Campbell, J G Kelly, R G Shanks, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Pharmacokinetics of amlodipine in renal impairmentM S Laher, J G Kelly, G D Doyle, et al.
Clinical Pharmacology and Therapeutics|November 1, 1976
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blockerH C Brown, S G Carruthers, G D Johnston, et al.
Pageof 13